Company: IPAR
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001753926-25-000424
Chunk: 26

Company: INTERPARFUMS INC
Filing Date: 2025-03-11
Form: 10-K
Item: Item 8
Chunk 26
---
The required financial statements commence on page F-1.

44    

Item 9.   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures. 

Evaluation of Disclosure Controls and Procedures 

Our Chief Executive Officer and Chief
Financial Officer have reviewed and evaluated the effectiveness of our
disclosure controls and procedures (as defined in the Securities Exchange Act
of 1934 Rule 13a-15(e)) as of the end of the period covered by this annual
report on Form 10-K (the “Evaluation Date”). In designing and evaluating the disclosure
controls and procedures, management recognized that any controls and
procedures, no matter how well designed and operated, could provide only
reasonable assurance of achieving the desired control objectives, and
management necessarily was required to apply its judgment in evaluating the
cost-benefit relationship of possible controls and procedures. Based
on this evaluation, the Company's Chief Executive Officer and Chief Financial
Officer concluded that, as a result of the material weaknesses in internal
control over financial reporting described below in “Management’s Annual Report
on Internal Control over Financial Reporting”, the Company’s disclosure
controls and procedures were not effective as of December 31, 2024. 

Management’s Annual Report on Internal Control over Financial Reporting

The management of Interparfums, Inc. is
responsible for establishing and maintaining adequate internal control over
financial reporting, as defined in Rule 13(a)-15(f) under the Securities
Exchange Act of 1934, to provide reasonable assurance regarding the reliability
of our financial reporting and the preparation of financial statements for
external purposes in accordance with U.S. generally accepted accounting
principles (“GAAP”). 

Because of its inherent limitations, internal
control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to
the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may
deteriorate. A material weakness is a deficiency, or combination of
deficiencies, in internal control over financial reporting, such that there is
a reasonable possibility that a material misstatement of the Company’s annual
or interim financial statements will not be prevented or detected on a timely
basis.

With
the participation of the Chief Executive Officer and the Chief Financial
Officer, our management conducted an evaluation of the effectiveness of our
internal control